Search

everythinglearnresearchcommunity

for

Search:↓

High-dose corticosteroids and methotrexate had a modest effect on severe childhood alopecia, but side effects and relapse were concerns.

A natural extract-based hair growth product was developed and showed promise in preliminary tests.

Ayurvedic treatment with Bhringraj Vati and coconut oil was safe and effective for reducing hair fall.

Certain medications including flutamide, spironolactone, and others effectively reduce excessive hair growth in women, especially when combined with lifestyle changes.

Alopecia in patients with epidermolysis bullosa varies in severity and is often caused by skin blistering or trauma.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Leflunomide and methotrexate are equally effective for rheumatoid arthritis but have different side effects.

Patients with PCOS tend to score their hirsutism higher than clinicians, making self-scoring less useful for diagnosis.

Azathioprine may help treat severe alopecia areata, but more research is needed.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

Alopecia patients have a less active liver monoxygenase system, which can be treated with photochemotherapy and system inducers.

Leflunomide and methotrexate are similarly effective for rheumatoid arthritis but have different side effects.

The digital system for measuring melasma shows promise but needs more development for better accuracy and automation.

Colchicine might help treat different skin diseases, but more research is needed to confirm its effectiveness and safe dosage.

Many patients with various medical conditions experience anxiety, which worsens their quality of life and raises healthcare costs.

Injectable treatments can effectively and safely improve hair growth in adults with androgenetic alopecia.

Regenerative medicine shows promise for treating skin disorders like hair loss and vitiligo.

Stem cell therapies show promise for hair regrowth in androgenetic alopecia.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

The developed system could effectively treat hair loss and promote hair growth.

Antiandrogen therapy for hidradenitis suppurativa lacks strong evidence and needs more research.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Chimp Haven uses a special system to check and improve the well-being of their chimpanzees, which could help other animal sanctuaries too.

DAVID syndrome is a condition with immune system and hormone deficiencies, needing early diagnosis to avoid serious complications.

Human scalp hair follicles can produce hormones and have a system similar to a brain-body communication network.

The CWARTS tool is a promising method for assessing warts and could improve treatment and research.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Men with more advanced male pattern baldness have a higher risk of prostate cancer and more severe disease.

Organ transplant recipients have a higher risk of skin cancer over time, atopic dermatitis skin shows unusual bacterial and fungal patterns, a new tool for measuring hidradenitis suppurativa severity was created, and gene expression changes in male baldness suggest new treatments.